Method development for pancreatic and ovarian cancer baseline ctDNA detection and measurable residual disease monitoring

Tim Alexander Steiert, Philipp M. Altrock, Axel Künstner, Vishal Dixit, Burkhard Brandt, Pamela Pinzani, Hauke Busch, Andre Franke, Michael Forster

Open source

DOI
10.12688/openreseurope.23403.1
Published
2026-04-03
Container
Open Research Europe
Publisher
F1000 Research Ltd
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.12688/openreseurope.23403.1,
  title = {Method development for pancreatic and ovarian cancer baseline ctDNA detection and measurable residual disease monitoring},
  author = {Tim Alexander Steiert and Philipp M. Altrock and Axel Künstner and Vishal Dixit and Burkhard Brandt and Pamela Pinzani and Hauke Busch and Andre Franke and Michael Forster},
  year = {2026},
  journal = {Open Research Europe},
  doi = {10.12688/openreseurope.23403.1},
  url = {https://doi.org/10.12688/openreseurope.23403.1}
}

RIS

TY  - JOUR
TI  - Method development for pancreatic and ovarian cancer baseline ctDNA detection and measurable residual disease monitoring
AU  - Tim Alexander Steiert
AU  - Philipp M. Altrock
AU  - Axel Künstner
AU  - Vishal Dixit
AU  - Burkhard Brandt
AU  - Pamela Pinzani
AU  - Hauke Busch
AU  - Andre Franke
AU  - Michael Forster
PY  - 2026
JO  - Open Research Europe
DO  - 10.12688/openreseurope.23403.1
UR  - https://doi.org/10.12688/openreseurope.23403.1
ER  - 

APA

Steiert, T. A., Altrock, P. M., Künstner, A., Dixit, V., Brandt, B., Pinzani, P., Busch, H., Franke, A., & Forster, M. (2026). Method development for pancreatic and ovarian cancer baseline ctDNA detection and measurable residual disease monitoring. Open Research Europe. https://doi.org/10.12688/openreseurope.23403.1

Source records